# New York Blood Center Enterprises – FDA Inspection, Feb 19, 2026

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/6ae5a8b8-deed-4007-8753-c6c7b04b715d
Source feed: FDA_Inspections

> FDA inspection 1303442 of New York Blood Center Enterprises, February 19, 2026. 3 citations under 21 CFR parts 600 and 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303442
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2026-02-19
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: New York District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1145747 - 2021-07-01
- FDA Inspection 1048445 - 2018-03-30
- FDA Inspection 969113 - 2016-04-21
- FDA Inspection 890624 - 2014-08-08
- FDA Inspection 811161 - 2012-12-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/6703559f-2570-40de-b8fa-62783593d610

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d